Immunohistochemical analyses have shown high expression of ERCC1 in ≈50% of HCCs and lower sensitivity to cisplatin in surgically resected HCC tissues with increased expression of ERCC1 [62]. This evidence concerns the gene ERCC1 and hepatocellular carcinoma.